SGLT2 Inhibitors Improve Day-to-Day Glucose Variability in Patients with Type 1 Diabetes

Chiba, K; Cho, K; Kameda, H; Nakamura, A; Shibayama, Y; Nomoto, H; Atsumi, T; Miyoshi, H

DIABETES, 2020; 69 ():